Table 1 Eligibility criteria for the INFORM RSV study
From: Global molecular diversity of RSV – the “INFORM RSV” study
| Inclusion Criteria | Exclusion Criteria |
|---|---|
| Age < 5 years | Use of palivizumab or experimental medication for RSV |
| Confirmed RSV positive diagnosis | |
| Written informed parental consent |